This product is for research use only and is not for human consumption or therapeutic use.
CAS Number:
1034895-42-5
Purity:
98.83
Molecular Weight:
404.35
Alternative Names:
Elraglusib
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
9-ING-41 (Elraglusib) is a maleimide-based ATP-competitive and selective glycogen synthase kinase-3β (GSK-3β) inhibitor with an IC50 of 0.71 µM. 9-ING-41 significantly leads to cell cycle arrest, autophagy and apoptosis in cancer cells. 9-ING-41 has anticancer activity and has the potential for enhancing the antitumor effects of chemotherapeutic agents[1][2][3][4].
Storage Temperature:
-20°C, 3 years; 4°C, 2 years (Powder)